Clostridium botulinum neurotoxins are known to be among the most potent and dangerous biological agents, because exposure to them can cause a life threatening paralytic disease syndrome. This IAA will support the development of monoclonal antibodies for neutralization of botulinum neurotoxin serotypes C, D, F and G, as well as support in vivo studies to characterize the potency of these antibodies.

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2012
Total Cost
$475,670
Indirect Cost
City
State
Country
Zip Code